United States · Series D startup

Who invested in Genome Medical

2 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechGenomicsHealthcare

Funding summaryUpdated 26 Oct 2026

$98Mraised across 2 rounds since 2019, from 2 sources

$23MSeries B$75MSeries D
Latest round
Series D, $75MSept 2024
Step-upi
3.3×
Investors
13 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20202021202220232024
$23MSeries B$75MSeries D
First round
Series B, $23M
Jun 2019
Biggest round
$75M
Series D · Sept 2024
Between rounds
5.3 years
from the last two

The rounds

  1. Sept 2024
    Series D$75M2 new5 returning

    Source recordedSEC filing: $75M sold, first sale Sept 2024

  2. Jun 2019

Founders and team

From Genome Medical's own website: 4 on the team.

  • Andrew WarnerVice President, Product
  • Clinical LeadsVice President, Engineering
  • Durand Van ArnemVice President, Engineering
  • Alan RopeMedical Director

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

CanaanVC firm2rounds
Perceptive AdvisorsAsset manager2rounds
Casdin CapitalVC firm2rounds
Illumina VenturesVC firm2rounds
LRVHealthVC firm2rounds
Echo Health VenturesPrivate equity1round, led 1
Alumni VenturesVC firm1round
Google VenturesCorporate VC1round
GE VenturesCorporate VC1round
Kaiser Permanente VenturesCorporate VC1round
Manatt Venture FundCorporate VC1round
Dreamers VCVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Genome Medical as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Samsung Catalyst FundCorporate VCPer its own site

Quick answers about Genome Medical

Who invested in Genome Medical?

Genome Medical's investors include Canaan, Perceptive Advisors, Casdin Capital, Illumina Ventures and LRVHealth, and 8 more on record.

How much has Genome Medical raised?

Genome Medical has raised $98M across 2 rounds since 2019.

When did Genome Medical last raise?

Genome Medical's most recent round was a Series D of $75M in Sept 2024.

What was Genome Medical's biggest round?

Its most recent round, $75M in Sept 2024, is also its largest on record.

Who backed Genome Medical first?

Genome Medical's first round on record, in Jun 2019, was backed by Echo Health Ventures, Canaan and Perceptive Advisors and 8 others.

What stage is Genome Medical at?

Genome Medical's latest named round is a Series D, in Sept 2024.

Where is Genome Medical based?

Genome Medical is based in the United States.

Who led Genome Medical's rounds?

Echo Health Ventures led the Series B in 2019.

Companies like Genome Medical

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.